Search

Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Recognizing the significant unmet needs in this cohort, we recently published a review of the latest treatment options.

… Wednesday, October 14, 2020 Pituitary adenomas continue to grow in a small subset of patients despite treatment with standard surgery and radiotherapy. Further treatments may provide symptom relief but are rarely definitive for disease management in this cohort. Recognizing the significant unmet needs

Learn more about world-class cancer care on Long Island at MSK Nassau.

… Tuesday, March 26, 2019 Summary Memorial Sloan Kettering has opened MSK Nassau , expanding its cancer care in Nassau County. The Uniondale facility includes a number of features designed to make treatment easier and more convenient. Memorial Sloan Kettering has been caring for people on Long Island for

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.

… Friday, February 2, 2018 Summary MSK investigators are reporting on a new approach for treating melanoma in the arm or leg. The therapy combines the immunotherapy drug ipilimumab with chemotherapy for only the affected limb. For some people with cancer, drugs that help the immune system recognize and

Our recent research demonstrates that the thrombopoietin receptor agonist romiplostim effectively modifies chemotherapy-induced thrombocytopenia (CIT) in solid tumor patients, allowing a majority to resume chemotherapy

… Friday, August 10, 2018 Our recent research demonstrates that the thrombopoietin receptor agonist romiplostim effectively modifies chemotherapy-induced thrombocytopenia (CIT) in solid tumor patients, allowing a majority to resume chemotherapy. In the phase II study, which included 32 patients, 84 percent

Approaches used for research into the social lives of bacteria can also be used to explore how tumors behave and evolve.

… Thursday, May 1, 2014 Summary Approaches used for research into the social lives of bacteria can also be used to explore how tumors behave and evolve. Computational biologist Joao Xavier has spent most of his career researching how bacterial cells interact with one another and produce complex group behaviors

Jeffrey Zwicker, MD, has been named Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from Harvard University Medical School, where he was an Associate Professor of Medicine, and Beth Israel Deaconess Medical Center (BIDMC), where he served as Chief of Benign Hematology in the Division of Hematology since 2017. Dr. Zwicker succeeds MSK’s Interim Hematology Service Chief, Marcel van den Brink, MD, PhD.

… Wednesday, November 30, 2022 Jeffrey Zwicker, MD ,   has been named Chief of the Hematology Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from Harvard University Medical School, where he was an Associate Professor of Medicine, and   Beth Israel Deaconess Medical Center (BIDMC)

In honor of Women's History Month, meet the scientific hero who helped raise money and awareness for AIDS research.

… Wednesday, March 13, 2019 Summary In honor of Women’s History Month, we’re remembering female scientists from MSK’s past who shook up cancer research. Read about Charlotte Friend and Ora Rosen . In 1981, Mathilde Krim, an immunologist at the Sloan Kettering Institute , was exploring the role of naturally

Memorial Sloan Kettering has announced the creation of the Louis V. Gerstner, Jr. Young Investigators Fund and has named the fund's first four recipients.

… Friday, May 1, 2009 Summary Memorial Sloan Kettering has announced the creation of the Louis V. Gerstner, Jr. Young Investigators Fund and has named the fund’s first four recipients. Memorial Sloan Kettering has announced the creation of the Louis V. Gerstner, Jr. Young Investigators Fund and has named

Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.

… Wednesday, March 30, 2016 Summary MSK researchers have made a surprising finding: A common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.

Meet MSK Research Scholar Moralba Dominguez Garcia, PhD: “I wanted to do something that creates knowledge — and that can help other people.”

… Friday, June 6, 2025 For Moralba (Mora) Dominguez Garcia, PhD , being a Research Scholar developing radiopharmaceuticals against cancer is a dream come true.  Like so many trainees who come to Memorial Sloan Kettering Cancer Center (MSK) from around the world after earning a PhD, she was drawn by the